Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
HD5afVYqc5U6SQ7h
Listen
